Respiratory infections
Symposium
New developments in pandemic medicine
Clinical
An update from the PREPARE EU research project
Aims : To describe the latest developments in antiviral therapy for influenza and the growing clinical problem of arbovirus infection in Europe; to evaluate the rationale for adaptive trials investigating critical care interventions in a pandemic; and to describe a collaborative strategy for increasing clinical and research capacity in Europe for pandemic care.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Respiratory critical care physician, Pathologist, Physician in Pulmonary Training, Respiratory physiotherapist, Scientist (basic, translational)
Chairs
E. Bel
Amsterdam
(Netherlands)
09:30
Introduction
1
3740
09:35
Antiviral therapy for influenza: latest trial results
C. Butler(Oxford (Oxfordshire), United Kingdom)
COI
-
Description
2
3741
09:45
New approaches to designing trials for pandemics: setting up an adaptive trial for management strategies in community acquired pneumonia
L. Derde(Utrecht, Netherlands)
COI
-
Description
3
3742
09:55
ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
L. Sigfrid(Oxford, United Kingdom)
COI
-
Description
4
3743
10:05
What's next - preparing for the ongoing COVID response and future pandemics
G. Carson(Oxford (Oxfordshire), United Kingdom)
COI
-
Description
5
3744
10:15
Discussion and Q&A
6
3745
. . .